Literature DB >> 12770942

Binding and effect of K ATP channel openers in the absence of Mg2+.

Ulrich Russ1, Ulf Lange, Cornelia Löffler-Walz, Annette Hambrock, Ulrich Quast.   

Abstract

1 Openers of ATP-sensitive K(+) channels (K(ATP) channels) are thought to act by enhancing the ATPase activity of sulphonylurea receptors (SURs), the regulatory channel subunits. At higher concentrations, some openers activate K(ATP) channels also in the absence of MgATP. Here, we describe binding and effect of structurally diverse openers in the absence of Mg(2+) and presence of EDTA. 2 Binding of openers to SUR2B was measured using a mutant with high affinity for [(3)H]glibenclamide ([(3)H]GBC). In the absence of Mg(2+), 'typical' openers (benzopyrans, cyanoguanidines and aprikalim) inhibited [(3)H]GBC binding with K(i) values approximately 200 x higher than in the presence of MgATP. Minoxidil sulphate and nicorandil were inactive, whereas binding of diazoxide was unaffected by MgATP. 3 In the absence/presence of MgATP, N-cyano-N'-(1,1-dimethylpropyl)-N"-3-pyridylguanidine (P1075) activated the Kir6.2/SUR2B channel in inside-out patches with EC(50)=2000/67nM and E(max)=32/134%. In the absence of Mg(2+), responses were variable with only a small part of the variability being explained by a decrease in channel responsiveness with time after patch excision and to differences in the ATP sensitivity between patches. 4 The rank order of efficacy of the openers was P1075>rilmakalim approximately nicorandil>diazoxide>minoxidil sulphate. 5 The data show that structurally diverse openers are able to bind to, and to activate the Kir6.2/SUR2B channel by a pathway independent of ATP hydrolysis. These effects are observed at concentrations used to define the biochemical mechanism of the openers in the presence of MgATP and allow the openers to be classified into 'typical' and 'atypical' KCOs with diazoxide standing apart.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12770942      PMCID: PMC1573839          DOI: 10.1038/sj.bjp.0705238

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  52 in total

1.  Adenosine diphosphate as an intracellular regulator of insulin secretion.

Authors:  C G Nichols; S L Shyng; A Nestorowicz; B Glaser; J P Clement; G Gonzalez; L Aguilar-Bryan; M A Permutt; J Bryan
Journal:  Science       Date:  1996-06-21       Impact factor: 47.728

2.  Nucleotide modulation of pinacidil stimulation of the cloned K(ATP) channel Kir6.2/SUR2A.

Authors:  F M Gribble; F Reimann; R Ashfield; F M Ashcroft
Journal:  Mol Pharmacol       Date:  2000-06       Impact factor: 4.436

3.  A family of sulfonylurea receptors determines the pharmacological properties of ATP-sensitive K+ channels.

Authors:  N Inagaki; T Gonoi; J P Clement; C Z Wang; L Aguilar-Bryan; J Bryan; S Seino
Journal:  Neuron       Date:  1996-05       Impact factor: 17.173

4.  Intracellular protons control the affinity of skeletal muscle ATP-sensitive K+ channels for potassium-channel-openers.

Authors:  C Forestier; Y Depresle; M Vivaudou
Journal:  FEBS Lett       Date:  1993-07-05       Impact factor: 4.124

5.  Cloning of the beta cell high-affinity sulfonylurea receptor: a regulator of insulin secretion.

Authors:  L Aguilar-Bryan; C G Nichols; S W Wechsler; J P Clement; A E Boyd; G González; H Herrera-Sosa; K Nguy; J Bryan; D A Nelson
Journal:  Science       Date:  1995-04-21       Impact factor: 47.728

6.  Pharmacological properties of ATP-sensitive K+ channels in mammalian skeletal muscle cells.

Authors:  B Allard; M Lazdunski
Journal:  Eur J Pharmacol       Date:  1993-06-04       Impact factor: 4.432

7.  Modulation by Mg2+ and ADP of ATP-sensitive potassium channels in frog skeletal muscle.

Authors:  C Forestier; M Vivaudou
Journal:  J Membr Biol       Date:  1993-02       Impact factor: 1.843

8.  Effect of MgATP on pinacidil-induced displacement of glibenclamide from the sulphonylurea receptor in a pancreatic beta-cell line and rat cerebral cortex.

Authors:  M Schwanstecher; C Brandt; S Behrends; U Schaupp; U Panten
Journal:  Br J Pharmacol       Date:  1992-06       Impact factor: 8.739

9.  Cloning and functional expression of the cDNA encoding a novel ATP-sensitive potassium channel subunit expressed in pancreatic beta-cells, brain, heart and skeletal muscle.

Authors:  H Sakura; C Ammälä; P A Smith; F M Gribble; F M Ashcroft
Journal:  FEBS Lett       Date:  1995-12-27       Impact factor: 4.124

10.  Mechanism of action of K channel openers on skeletal muscle KATP channels. Interactions with nucleotides and protons.

Authors:  C Forestier; J Pierrard; M Vivaudou
Journal:  J Gen Physiol       Date:  1996-04       Impact factor: 4.086

View more
  9 in total

Review 1.  Mechanisms of drug combinations: interaction and network perspectives.

Authors:  Jia Jia; Feng Zhu; Xiaohua Ma; Zhiwei Cao; Zhiwei W Cao; Yixue Li; Yixue X Li; Yu Zong Chen
Journal:  Nat Rev Drug Discov       Date:  2009-02       Impact factor: 84.694

2.  The mutation Y1206S increases the affinity of the sulphonylurea receptor SUR2A for glibenclamide and enhances the effects of coexpression with Kir6.2.

Authors:  Damian Stephan; Eva Stauss; Ulf Lange; Holger Felsch; Cornelia Löffler-Walz; Annette Hambrock; Ulrich Russ; Ulrich Quast
Journal:  Br J Pharmacol       Date:  2005-04       Impact factor: 8.739

3.  Substitution of the Walker A lysine by arginine in the nucleotide-binding domains of sulphonylurea receptor SUR2B: effects on ligand binding and channel activity.

Authors:  Tobias Amann; Sophie Schell; Petra Kühner; Marcus Winkler; Mathias Schwanstecher; Ulrich Russ; Ulrich Quast
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-03-30       Impact factor: 3.000

4.  Cantú syndrome is caused by mutations in ABCC9.

Authors:  Bregje W M van Bon; Christian Gilissen; Dorothy K Grange; Raoul C M Hennekam; Hülya Kayserili; Hartmut Engels; Heiko Reutter; John R Ostergaard; Eva Morava; Konstantinos Tsiakas; Bertrand Isidor; Martine Le Merrer; Metin Eser; Nienke Wieskamp; Petra de Vries; Marloes Steehouwer; Joris A Veltman; Stephen P Robertson; Han G Brunner; Bert B A de Vries; Alexander Hoischen
Journal:  Am J Hum Genet       Date:  2012-05-17       Impact factor: 11.025

5.  Effect of rilmakalim on detrusor contraction in the presence and absence of urothelium.

Authors:  Melinda Wuest; Susann Kaden; Oliver W Hakenberg; Manfred P Wirth; Ursula Ravens
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-11-11       Impact factor: 3.000

6.  Role of the amino-terminal transmembrane domain of sulfonylurea receptor SUR2B for coupling to K(IR)6.2, ligand binding, and oligomerization.

Authors:  Marcus Winkler; Petra Kühner; Ulrich Russ; David Ortiz; Joseph Bryan; Ulrich Quast
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-11-17       Impact factor: 3.000

7.  Pinacidil induces vascular dilation and hyperemia in vivo and does not impact biophysical properties of neurons and astrocytes in vitro.

Authors:  Rosa Cao; Bryan T Higashikubo; Jessica Cardin; Ulf Knoblich; Raddy Ramos; Mark T Nelson; Christopher I Moore; Joshua C Brumberg
Journal:  Cleve Clin J Med       Date:  2009-04       Impact factor: 2.321

8.  Interaction of a novel dihydropyridine K+ channel opener, A-312110, with recombinant sulphonylurea receptors and KATP channels: comparison with the cyanoguanidine P1075.

Authors:  Holger Felsch; Ulf Lange; Annette Hambrock; Cornelia Löffler-Walz; Ulrich Russ; William A Carroll; Murali Gopalakrishnan; Ulrich Quast
Journal:  Br J Pharmacol       Date:  2004-03-15       Impact factor: 8.739

9.  Role for SUR2A ED domain in allosteric coupling within the K(ATP) channel complex.

Authors:  Amy B Karger; Sungjo Park; Santiago Reyes; Martin Bienengraeber; Roy B Dyer; Andre Terzic; Alexey E Alekseev
Journal:  J Gen Physiol       Date:  2008-03       Impact factor: 4.086

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.